Literature DB >> 22282239

PI3K-like kinases restrain Pim gene expression in endothelial cells.

Xinwen Min1,2, Jie Tang3, Yinfang Wang4, Minghua Yu3, Libing Zhao2, Handong Yang2, Peng Zhang2, Yexin Ma5.   

Abstract

Pim kinases contribute to tumor formation and development of lymphoma, which shows enhanced DNA replication, DNA recombination and repair. Endothelial cells^(ECs) express all the three members of Pim kinase gene family. We hypothesized that DNA repair gene would regulate Pim expression in ECs. Human umbilical vein endothelial cells (HUVECs) were isolated and maintained in M199 culture medium. The cellular distribution of Pim-3 in ECs was determined by immunofluorescent staining. The siRNA fragments were synthesized and transfected by using Lipofectamine LTX. The total cellular RNA was extracted from the cells by using Trizol reagent. cDNAs were quantified by semi-quantity PCR. The effects of LY294002 and wortmannin on RNA stability in ECs were also examined. Our data showed that LY294002 and wortmannin, phosphatidylinositol 3-kinase (PI3K) and PI3K-like kinase inhibitors, increased Pim mRNA expression in ECs without altering the mRNA stability. RNA interference (RNAi) targeting DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia telangiectasia mutated (ATM) increased mRNA expression of Pim-3 and Pim-1, respectively. Silencing of Akt decreased Pim-1 instead of Pm-2 and Pim-3 gene expression in ECs. But etoposide, a nucleoside analogue, which could activate DNA-PKcs and ATM, increased Pim expression in ECs. Our study indicates that the expression of Pim kinases is physiologically related to DNA-PKcs and ATM in ECs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282239     DOI: 10.1007/s11596-012-0003-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  31 in total

1.  PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins.

Authors:  Benjamin Deneen; Scott M Welford; Thu Ho; Felicia Hernandez; Irwin Kurland; Christopher T Denny
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

2.  The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.

Authors:  Malte Bachmann; Christian Kosan; Pei Xiang Xing; Mathias Montenarh; Ingrid Hoffmann; Tarik Möröy
Journal:  Int J Biochem Cell Biol       Date:  2005-11-08       Impact factor: 5.085

Review 3.  Endothelial cell migration during angiogenesis.

Authors:  Laurent Lamalice; Fabrice Le Boeuf; Jacques Huot
Journal:  Circ Res       Date:  2007-03-30       Impact factor: 17.367

4.  Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.

Authors:  M Breuer; R Slebos; S Verbeek; M van Lohuizen; E Wientjens; A Berns
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

5.  Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage.

Authors:  Christopher M Sturgeon; Zachary A Knight; Kevan M Shokat; Michel Roberge
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

6.  pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.

Authors:  D Wingett; A Long; D Kelleher; N S Magnuson
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

7.  Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice.

Authors:  T Möröy; A Grzeschiczek; S Petzold; K U Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice.

Authors:  Silvia Espejel; Marta Martín; Peter Klatt; Juan Martín-Caballero; Juana M Flores; María A Blasco
Journal:  EMBO Rep       Date:  2004-04-23       Impact factor: 8.807

9.  Pim-1 associates with protein complexes necessary for mitosis.

Authors:  Nandini Bhattacharya; Zeping Wang; Christine Davitt; Ian F C McKenzie; Pei-Xiang Xing; Nancy S Magnuson
Journal:  Chromosoma       Date:  2002-05-15       Impact factor: 4.316

10.  Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression.

Authors:  J S Krumenacker; D J Buckley; M A Leff; J T McCormack; G de Jong; P W Gout; J C Reed; T Miyashita; N S Magnuson; A R Buckley
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

View more
  2 in total

1.  PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

Authors:  Esperanza Martín-Sánchez; Lina Odqvist; Socorro M Rodríguez-Pinilla; Margarita Sánchez-Beato; Giovanna Roncador; Beatriz Domínguez-González; Carmen Blanco-Aparicio; Ana M García Collazo; Esther González Cantalapiedra; Joaquín Pastor Fernández; Soraya Curiel del Olmo; Helena Pisonero; Rebeca Madureira; Carmen Almaraz; Manuela Mollejo; F Javier Alves; Javier Menárguez; Fernando González-Palacios; José Luis Rodríguez-Peralto; Pablo L Ortiz-Romero; Francisco X Real; Juan F García; James R Bischoff; Miguel A Piris
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

Review 2.  PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.

Authors:  Aziz Ur Rehman Aziz; Sumbal Farid; Kairong Qin; Hanqin Wang; Bo Liu
Journal:  Biomolecules       Date:  2018-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.